| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/08/1992 | WO1992013524A1 Pharmaceutical for treating viral diseases |
| 08/08/1992 | WO1992013523A1 Pharmaceutical product for treating viral diseases |
| 08/08/1992 | CA2079868A1 Pharmaceutical for treating viral diseases |
| 08/08/1992 | CA2079867A1 Pharmaceutical product for treating viral diseases |
| 08/08/1992 | CA2038789A1 Antiperspirant formulations |
| 08/06/1992 | WO1992013521A1 Osmotic device for delayed delivery of agent |
| 08/06/1992 | WO1992012989A1 New sterol esters and sterol phosphorus compounds |
| 08/06/1992 | WO1992012960A2 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 08/06/1992 | WO1992012735A1 Composition containing ultrafine particles of magnetic metal oxide |
| 08/06/1992 | WO1992012713A1 Compositions |
| 08/06/1992 | WO1992012710A1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 08/06/1992 | WO1992012633A1 Carrier for active agents, and solid dosage forms prepared therewith |
| 08/06/1992 | CA2098992A1 Osmotic device for delayed delivery of agent |
| 08/05/1992 | EP0497724A1 An agent for disintegrating gallstones |
| 08/05/1992 | EP0497658A1 Use of (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)1H-azole derivatives for the preparation of medicines for the treatment of troubles of the capability of knowing functions |
| 08/05/1992 | EP0497626A1 Temperature activated controlled release device |
| 08/05/1992 | EP0497476A2 Antiplaque oral compositions |
| 08/05/1992 | EP0497439A1 Erythritol compositions |
| 08/05/1992 | EP0497353A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 08/05/1992 | EP0497331A2 Process for the preparation of tablets or film-coated tablets |
| 08/05/1992 | EP0497240A1 Preparation for controlled release of drugs for ruminants |
| 08/05/1992 | EP0497177A1 Vitamin containing formulations and their production |
| 08/05/1992 | EP0497162A1 Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 08/05/1992 | EP0497158A1 Pharmaceutical chewing-gum containing acetylsalicylic acid |
| 08/05/1992 | EP0496824A1 Reconstitution method. |
| 08/05/1992 | EP0496819A1 Direct compression carrier composition |
| 08/05/1992 | EP0490944A4 Transmucosal dosage form |
| 08/05/1992 | EP0348431B1 Liposome-incorporated nystatin |
| 08/05/1992 | EP0261213B1 Formulation for preparing sustained release drugs for oral administration |
| 08/05/1992 | EP0248885B1 Transdermal delivery of drugs |
| 08/05/1992 | CN1063222A Preparation process of traditional chinese medicine plaster for cutaneous absorption |
| 08/04/1992 | US5136014 Hyperbranched polyesters |
| 08/04/1992 | US5135920 Angiostatic agents |
| 08/04/1992 | US5135917 Bind to sense DNA strand coding for receptors |
| 08/04/1992 | US5135757 Compressible sustained release solid dosage forms |
| 08/04/1992 | US5135755 Composed of polyols, biopolymers, crosslinked with vinyl-carboxylic acids and salts, and water; high absorption |
| 08/04/1992 | US5135753 Method and therapeutic system for smoking cessation |
| 08/04/1992 | US5135752 Buccal dosage form |
| 08/04/1992 | US5135740 Porous particles in preparations involving immiscible phases |
| 08/04/1992 | US5135523 Delivery system for administering agent to ruminants and swine |
| 08/02/1992 | CA2060113A1 Temperature activated controlled release device |
| 07/31/1992 | CA2060068A1 Pharmaceutical chewing gum containing acetylsalicylic acid |
| 07/30/1992 | DE4101873A1 Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustaende Orally administered drug form for treatment central dopaminmangelzustaende |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496705A1 Composition especially adapted for encapsulation in a solid shell and process for preparing same |
| 07/29/1992 | EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole |
| 07/29/1992 | EP0496316A1 Pour-on formulation for application of anthelminthics |
| 07/29/1992 | EP0496308A1 Intranasal compositions comprising 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methynesulphonamide |
| 07/29/1992 | EP0496307A1 Compositions for intranasal administration comprising sumatriptan |
| 07/29/1992 | EP0496299A2 Diluent for perfluorocarbones used in retina deployment |
| 07/29/1992 | EP0496233A1 Pharmaceutical compositions for oral use containing low molecular weight heparin, their preparation and use |
| 07/29/1992 | EP0496138A1 Atropine-salbutamol aerosol |
| 07/29/1992 | EP0495918A1 Amino acid beta-lyase enzyme inhibitors as deodorants. |
| 07/29/1992 | EP0346501B1 Pharmaceutical preparation for treating immunodeficiency conditions |
| 07/29/1992 | EP0308460B1 A composition for the topical treatment of glaucoma or ocular hypertension |
| 07/29/1992 | EP0235259B1 Novel transdermal anti-anginal pharmaceutical dosage unit and process for its administration |
| 07/29/1992 | CN1063100A Heterocyclic compounds |
| 07/29/1992 | CN1063046A Close vascularization implant material |
| 07/29/1992 | CN1063042A Preparation method for rhizoma coptidis aerosol |
| 07/29/1992 | CN1063039A Solid dosage of almokalant and processes for manufacture thereof |
| 07/29/1992 | CA2060066A1 Preparation for the sustained release of active substances which are suitable as a therapeutic system or for improving growth and feed utilization in ruminants |
| 07/28/1992 | US5134164 Use of 3-guanidinopropionic acid in the treatment of excess adiposity |
| 07/28/1992 | US5134163 Retinoic acid for stretch marks |
| 07/28/1992 | US5134162 Method for lowering high blood cholesterol levels in hyperlipidemic animals and confections as the ingestion medium |
| 07/28/1992 | US5134130 Lipid emulsion for treating aids |
| 07/28/1992 | US5134127 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 07/28/1992 | US5134122 Salts of peptides, sustained release |
| 07/28/1992 | US5133974 Time release agents formed with binders and coatings over a core |
| 07/28/1992 | US5133973 Pharmaceutical preparations |
| 07/28/1992 | US5133972 Topically administrable pharmaceutical preparations |
| 07/28/1992 | US5133970 Water-soluble pressure-sensitive skin-adhesive and use thereof |
| 07/28/1992 | US5133965 Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution |
| 07/28/1992 | US5133908 Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles |
| 07/28/1992 | CA1305671C Photostable cosmetic preparation containing a uv-a filter and a uv-b filter, its use to protect the skin against uv rays and technique of stabilization of the uv-a filter by the uv-b filter |
| 07/28/1992 | CA1305670C Stable and quick-breaking topical skin compositions |
| 07/28/1992 | CA1305669C Method for inhibiting aging |
| 07/28/1992 | CA1305668C Multivitamin preparation |
| 07/27/1992 | CA2059977A1 Agent for disintegrating gallstones |
| 07/26/1992 | WO1992012704A1 Method for masking the taste of a medicament |
| 07/26/1992 | CA2077658A1 Method for masking the taste of a medicament |
| 07/26/1992 | CA2059984A1 1-h-azole-(w-(4-(2-pyrimidimyl)-1-piperazinyl)-alkyl) derivatives for the preparation of drugs useful for the treatment of cognitive troubles |
| 07/26/1992 | CA2059431A1 X-ray contrast compositions useful in medical imaging |
| 07/25/1992 | WO1992012729A1 Monoclonal antibodies to elam-1 and their uses |
| 07/25/1992 | WO1992012712A1 Compositions |
| 07/25/1992 | CA2100681A1 Monoclonal antibodies to elam-1 and their uses |
| 07/25/1992 | CA2100569A1 Compositions |
| 07/23/1992 | WO1992011896A1 Drug delivery system |
| 07/23/1992 | WO1992011873A1 Echo contrast agent |
| 07/23/1992 | WO1992011871A1 Stable suspension formulations for controlled delivery of pharmaceutical compounds |
| 07/23/1992 | WO1992011849A1 Swallowable pharmaceutical compositions |
| 07/23/1992 | WO1992011848A1 Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
| 07/23/1992 | WO1992011846A1 Particulates |
| 07/23/1992 | WO1992011843A1 Bioerodible devices and compositions for diffusional release of agents |
| 07/23/1992 | WO1992011842A1 Liposomal-polyene preliposomal powder and method for its preparation |
| 07/22/1992 | EP0495743A1 A composition comprising an active ingredient, preferably being powdery or particulate, and a carrier for said active ingredient as well as a method for the preparation of such composition |
| 07/22/1992 | EP0495441A2 Feed additive for ruminants |
| 07/22/1992 | EP0495421A1 Use of carrageenans in topical ophthalmic compositions |
| 07/22/1992 | EP0495349A2 Composition of an active agent for oral administration, especially to ruminants |
| 07/22/1992 | EP0495321A1 Rapid miosis with control of intraocular pressure |
| 07/22/1992 | EP0495270A1 Azaribine composition |